JP2015007118A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015007118A5 JP2015007118A5 JP2014183841A JP2014183841A JP2015007118A5 JP 2015007118 A5 JP2015007118 A5 JP 2015007118A5 JP 2014183841 A JP2014183841 A JP 2014183841A JP 2014183841 A JP2014183841 A JP 2014183841A JP 2015007118 A5 JP2015007118 A5 JP 2015007118A5
- Authority
- JP
- Japan
- Prior art keywords
- ether compound
- phospholipid ether
- diagnostic composition
- fluorescent phospholipid
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 28
- -1 phospholipid ether compound Chemical class 0.000 claims 28
- 201000011510 cancer Diseases 0.000 claims 17
- 230000003211 malignant Effects 0.000 claims 10
- 210000001519 tissues Anatomy 0.000 claims 10
- 210000000130 stem cell Anatomy 0.000 claims 8
- 238000009825 accumulation Methods 0.000 claims 7
- 230000001575 pathological Effects 0.000 claims 7
- 238000003384 imaging method Methods 0.000 claims 3
- 206010052360 Colorectal adenocarcinoma Diseases 0.000 claims 2
- 210000003238 Esophagus Anatomy 0.000 claims 2
- 208000005017 Glioblastoma Diseases 0.000 claims 2
- 206010025650 Malignant melanoma Diseases 0.000 claims 2
- 206010033128 Ovarian cancer Diseases 0.000 claims 2
- 208000008443 Pancreatic Carcinoma Diseases 0.000 claims 2
- 206010060862 Prostate cancer Diseases 0.000 claims 2
- 206010046766 Uterine cancer Diseases 0.000 claims 2
- 210000004027 cells Anatomy 0.000 claims 2
- 201000001441 melanoma Diseases 0.000 claims 2
- 210000000056 organs Anatomy 0.000 claims 2
- 201000002528 pancreatic cancer Diseases 0.000 claims 2
- 210000000683 Abdominal Cavity Anatomy 0.000 claims 1
- 210000000621 Bronchi Anatomy 0.000 claims 1
- 210000001072 Colon Anatomy 0.000 claims 1
- 210000001953 Common Bile Duct Anatomy 0.000 claims 1
- 210000001198 Duodenum Anatomy 0.000 claims 1
- 210000003734 Kidney Anatomy 0.000 claims 1
- 210000004072 Lung Anatomy 0.000 claims 1
- 210000000214 Mouth Anatomy 0.000 claims 1
- 210000000496 Pancreas Anatomy 0.000 claims 1
- 210000000664 Rectum Anatomy 0.000 claims 1
- 210000002784 Stomach Anatomy 0.000 claims 1
- 210000000115 Thoracic Cavity Anatomy 0.000 claims 1
- 210000003932 Urinary Bladder Anatomy 0.000 claims 1
- 210000004291 Uterus Anatomy 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000014759 maintenance of location Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 210000000813 small intestine Anatomy 0.000 claims 1
- 0 C=NNc(cc1)ccc1C(C1=CC=C*1*1(N)N)=C2*1=CC=C2 Chemical compound C=NNc(cc1)ccc1C(C1=CC=C*1*1(N)N)=C2*1=CC=C2 0.000 description 1
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/463,983 | 2009-05-11 | ||
| US12/463,983 US20100286510A1 (en) | 2009-05-11 | 2009-05-11 | Use of fluorescent phospholipid ether compounds in biopsies |
| US12/463,970 | 2009-05-11 | ||
| US12/463,970 US7811548B1 (en) | 2009-05-11 | 2009-05-11 | Fluorescent phospholipid ether compounds and compositions |
| US12/463,978 US20100284929A1 (en) | 2009-05-11 | 2009-05-11 | Fluorescent imaging of tumors using phospholipid ether compounds |
| US12/463,998 US20100284931A1 (en) | 2009-05-11 | 2009-05-11 | Fluorescent phospholipid ether compounds, compositions, and methods of use |
| US12/463,990 | 2009-05-11 | ||
| US12/463,978 | 2009-05-11 | ||
| US12/463,998 | 2009-05-11 | ||
| US12/463,990 US20100284930A1 (en) | 2009-05-11 | 2009-05-11 | Fluorescent imaging of skin cancers using phospholipid ether compounds |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012510929A Division JP5702366B2 (ja) | 2009-05-11 | 2010-05-11 | 蛍光リン脂質エーテル化合物、組成物、及びその使用 |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015098391A Division JP6073961B2 (ja) | 2009-05-11 | 2015-05-13 | 蛍光リン脂質エーテル化合物、組成物、及びその使用 |
| JP2016089336A Division JP2016193907A (ja) | 2009-05-11 | 2016-04-27 | 蛍光リン脂質エーテル化合物、組成物、及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015007118A JP2015007118A (ja) | 2015-01-15 |
| JP2015007118A5 true JP2015007118A5 (zh) | 2015-07-02 |
| JP6006271B2 JP6006271B2 (ja) | 2016-10-12 |
Family
ID=43085298
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012510929A Active JP5702366B2 (ja) | 2009-05-11 | 2010-05-11 | 蛍光リン脂質エーテル化合物、組成物、及びその使用 |
| JP2014183841A Active JP6006271B2 (ja) | 2009-05-11 | 2014-09-10 | 蛍光リン脂質エーテル化合物、組成物、及びその使用 |
| JP2015098391A Active JP6073961B2 (ja) | 2009-05-11 | 2015-05-13 | 蛍光リン脂質エーテル化合物、組成物、及びその使用 |
| JP2016089336A Pending JP2016193907A (ja) | 2009-05-11 | 2016-04-27 | 蛍光リン脂質エーテル化合物、組成物、及びその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012510929A Active JP5702366B2 (ja) | 2009-05-11 | 2010-05-11 | 蛍光リン脂質エーテル化合物、組成物、及びその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015098391A Active JP6073961B2 (ja) | 2009-05-11 | 2015-05-13 | 蛍光リン脂質エーテル化合物、組成物、及びその使用 |
| JP2016089336A Pending JP2016193907A (ja) | 2009-05-11 | 2016-04-27 | 蛍光リン脂質エーテル化合物、組成物、及びその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US9616140B2 (zh) |
| EP (1) | EP2429591B1 (zh) |
| JP (4) | JP5702366B2 (zh) |
| ES (1) | ES2549459T3 (zh) |
| WO (1) | WO2010132428A1 (zh) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2429591B1 (en) * | 2009-05-11 | 2015-08-26 | Cellectar, Inc. | Fluorescent phospholipid ether compounds, compositions, and methods of use |
| SI3708192T1 (sl) | 2009-06-12 | 2023-12-29 | Cellectar, Inc. | Eter fosfolipidne spojine za zdravljenje raka in slikanje in detekcijo rakavih izvornih celic |
| JP2013032297A (ja) * | 2011-08-01 | 2013-02-14 | Univ Of Tsukuba | バイオイメージングのための近赤外発光物質及びその合成方法 |
| JP6260259B2 (ja) * | 2013-12-24 | 2018-01-17 | 日油株式会社 | ボロン酸含有ホスホリルコリン化合物及びその製造方法、並びにヨード基含有化合物修飾剤 |
| US9925269B2 (en) | 2014-11-17 | 2018-03-27 | Cellectar Biosciences, Inc. | Phospholipid ether analogs as cancer-targeting drug vehicles |
| US10265398B2 (en) | 2015-11-06 | 2019-04-23 | Wisconsin Alumni Research Foundation | Long-lived gadolinium based tumor targeted imaging and therapy agents |
| BR112018077197A2 (pt) * | 2016-06-14 | 2019-08-20 | Pinchuk Anatoly | análogos de éter de fosfolipídio para identificação e isolamento de células tumorais circulantes |
| KR102148067B1 (ko) * | 2016-09-02 | 2020-08-26 | 주식회사 엘지화학 | 화합물 및 이를 포함하는 색변환필름 |
| JP2020066637A (ja) * | 2017-02-27 | 2020-04-30 | 富士フイルム株式会社 | 病理診断用染色剤、細胞核染色方法、病理標本の製造方法、及び色素 |
| JP6495989B1 (ja) | 2017-10-02 | 2019-04-03 | 株式会社アマダホールディングス | プログラム作成装置、溶接システム、及びプログラム作成方法 |
| EP3805236A4 (en) | 2018-06-01 | 2021-07-28 | FUJIFILM Corporation | FLUORESCENT COMPOUND AND BIOLOGICAL SUBSTANCE MARKED BY FLUORESCENCE USING IT |
| KR102400464B1 (ko) * | 2020-07-28 | 2022-05-19 | 부산대학교 산학협력단 | 암 줄기세포 검출용 바이오 마커 조성물 |
| EP4168501A1 (en) | 2020-09-05 | 2023-04-26 | Council Of Scientific & Industrial Research | A thermoresponsive self-assembled organic material as photonic ink and a process of making thereof |
| CN114957330A (zh) * | 2022-07-06 | 2022-08-30 | 南京师范大学 | 一种新型花菁染料中间体及其制备方法 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4925649A (en) | 1987-06-12 | 1990-05-15 | The University Of Michigan | Radioiodinated diacylglycerol analogues and methods of use |
| US4965391A (en) | 1987-10-23 | 1990-10-23 | The University Of Michigan | Radioiodinated phospholipid ether analogues |
| US5087721A (en) | 1987-10-23 | 1992-02-11 | The University Of Michigan | Radioiodinated phosphate esters |
| US5347030A (en) | 1987-10-23 | 1994-09-13 | The Board Of Regents Of The University Of Michigan | Radioiodinated phospholipid ether analogues and methods of using same |
| US5369097A (en) | 1991-04-25 | 1994-11-29 | The University Of British Columbia | Phosphonates as anti-cancer agents |
| US5728529A (en) * | 1995-06-23 | 1998-03-17 | Baylor College Of Medicine | Alternative dye-labeled ribonucleotides, deoxyribonucleotides, and dideoxyribonucleotides for automated DNA analysis |
| US5626654A (en) | 1995-12-05 | 1997-05-06 | Xerox Corporation | Ink compositions containing liposomes |
| WO1998024480A1 (en) | 1996-12-04 | 1998-06-11 | The Regents Of The University Of Michigan | Radioiodinated phospholipid ether analogs and methods of using the same |
| US6255519B1 (en) | 1996-12-04 | 2001-07-03 | Regents Of The University Of Michigan | Radioiodinated phospholipid ether analogs and methods of using the same |
| US5830701A (en) * | 1997-03-28 | 1998-11-03 | Tao Medical Electronics Co., Ltd. | Method of detecting hematopoietic progenitor cells |
| US6939985B1 (en) | 1997-04-09 | 2005-09-06 | Commonwealth Scientific And Industrial Research Organisation | Aryl borates |
| ATE372359T1 (de) * | 2002-07-18 | 2007-09-15 | Protein Express Co Ltd | Aminoacyl-trna geunden an markierte p- aminophenylalanine oder tyrosine |
| JP4004385B2 (ja) * | 2002-11-07 | 2007-11-07 | 独立行政法人科学技術振興機構 | 二重染色法によるガン検出方法 |
| WO2005063774A1 (en) | 2003-12-22 | 2005-07-14 | Johns Hopkins University | Boronic acid aryl analogs |
| JP2007528374A (ja) | 2004-03-02 | 2007-10-11 | セレクター，リミティド ライアビリティ カンパニー | Ｄｉａｐｅｕｔｉｃ（登録商標）剤としてのリン脂質類似体、及びその方法 |
| US8540968B2 (en) * | 2004-03-02 | 2013-09-24 | Cellectar, Inc. | Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof |
| NZ552914A (en) | 2004-07-08 | 2009-12-24 | Cellectar Inc | Virtual colonoscopy with radiolabeled 18-(4-iodophenyl)-octadecylphosphocholine (NM404) |
| US7041859B1 (en) | 2004-09-09 | 2006-05-09 | University Of Tennessee Research Foundation | Method for halogenating or radiohalogenating a chemical compound |
| KR20080005178A (ko) * | 2004-12-20 | 2008-01-10 | 셀렉타, 엘엘씨 | 암 검출 및 치료용 인지질 에테르 동족체 |
| JP2007143624A (ja) * | 2005-11-24 | 2007-06-14 | Hamamatsu Photonics Kk | 蛍光観察装置 |
| US20070297988A1 (en) * | 2006-06-21 | 2007-12-27 | Bin Wu | Optical probes for in vivo imaging |
| US20080075660A1 (en) * | 2006-08-15 | 2008-03-27 | Cellectar, Llc | Near infrared-fluorescence using phospholipid ether analog dyes in endoscopic applications |
| WO2008150439A1 (en) | 2007-06-01 | 2008-12-11 | Cellectar, Inc. | Compositions of phospholipid ether boronic acids and esters and methods for their synthesis and use |
| ES2326458B1 (es) * | 2008-04-04 | 2010-07-26 | Consejo Superior De Investigaciones Cientificas (Csic) (85%) | Compuestos fluorescentes para diagnostico de infecciones, procedimiento de obtencion y sus aplicaciones. |
| US20100284930A1 (en) | 2009-05-11 | 2010-11-11 | Pinchuk Anatoly | Fluorescent imaging of skin cancers using phospholipid ether compounds |
| US7811548B1 (en) | 2009-05-11 | 2010-10-12 | Cellectar, Inc. | Fluorescent phospholipid ether compounds and compositions |
| US20100284929A1 (en) | 2009-05-11 | 2010-11-11 | Pinchuk Anatoly | Fluorescent imaging of tumors using phospholipid ether compounds |
| US20100284931A1 (en) | 2009-05-11 | 2010-11-11 | Pinchuk Anatoly | Fluorescent phospholipid ether compounds, compositions, and methods of use |
| EP2429591B1 (en) * | 2009-05-11 | 2015-08-26 | Cellectar, Inc. | Fluorescent phospholipid ether compounds, compositions, and methods of use |
| US20100286510A1 (en) | 2009-05-11 | 2010-11-11 | Pinchuk Anatoly | Use of fluorescent phospholipid ether compounds in biopsies |
| US8871181B2 (en) | 2009-05-11 | 2014-10-28 | Cellectar, Inc. | Fluorescent phospholipid ether compounds, compositions, and methods of use |
| SI3708192T1 (sl) | 2009-06-12 | 2023-12-29 | Cellectar, Inc. | Eter fosfolipidne spojine za zdravljenje raka in slikanje in detekcijo rakavih izvornih celic |
-
2010
- 2010-05-11 EP EP10775385.7A patent/EP2429591B1/en active Active
- 2010-05-11 JP JP2012510929A patent/JP5702366B2/ja active Active
- 2010-05-11 ES ES10775385.7T patent/ES2549459T3/es active Active
- 2010-05-11 WO PCT/US2010/034361 patent/WO2010132428A1/en active Application Filing
-
2014
- 2014-09-10 JP JP2014183841A patent/JP6006271B2/ja active Active
- 2014-09-23 US US14/493,489 patent/US9616140B2/en active Active
-
2015
- 2015-05-13 JP JP2015098391A patent/JP6073961B2/ja active Active
-
2016
- 2016-04-27 JP JP2016089336A patent/JP2016193907A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015007118A5 (zh) | ||
| Rizzo et al. | Circulating tumor DNA in biliary tract cancer: current evidence and future perspectives | |
| JP2012526822A5 (zh) | ||
| Gao et al. | Early esophageal cancer screening in China | |
| Zhao et al. | Role of EZH2 in oral squamous cell carcinoma carcinogenesis | |
| RU2016128396A (ru) | Новые способы лечения рака | |
| Goldiş et al. | Comparative analysis of microvessel density quantified through the immunohistochemistry expression of CD34 and CD105 in rectal cancer | |
| Ando et al. | Secondary resistance of extra-gastrointestinal stromal tumors to imatinib mesylate: Report of a case | |
| Xu et al. | AB065. EP4 antagonist suppresses bone metastasis in prostate cancer | |
| Xu et al. | AB064. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer | |
| Fuccio et al. | Risk factors for stent-related adverse events in patients with obstructive colorectal cancer: Are we missing something? | |
| Deantonio et al. | Hypofractionated volumetric modulated arc therapy (VMAT) in the treatment of advanced oesophageal cancer | |
| WO2022246002A2 (en) | Methods and compositions for determining cancer risk | |
| Raczkowska-Łabuda et al. | HPV-related head and neck tumors–10 years of experience with human papillomavirus vaccinations | |
| Ohtsuka et al. | 610 Observation of Human Stomach by Using a Body-Friendly and Self-Propelling Capsule Endoscope | |
| Succony et al. | S9 The role of LRIG1-dependent EGFR signalling in airway homoeostasis and squamous cell lung cancer development | |
| Anis et al. | Gastric synchronous stromal tumor and adenocarcinoma: A fortuitous association | |
| Dimitroulopoulos et al. | Synchronous occurrence of colorectal adenocarcinoma and colonic gastrointestinal stromal tumor (GIST). A case report | |
| Zhao et al. | IDDF2019-ABS-0188 Gut microbiota modulates the chemopreventive efficacy of aspirin on colorectal cancer through impact on aspirin bioavailability | |
| Terada | Appendiceal diverticulitis clinically masquerading as an appendiceal carcinoma | |
| Daram et al. | Esophageal hemangiolymphangioma | |
| Kim et al. | The Korean Society of Gastroenterology & SIDDS 2048: Slide Session; K-LG-19: Lower GI Tract; Cold Snare Polypectomy Versus Cold Forceps Polypectomy for Diminutive and Small Colorectal Polyps: A Randomized Controlled Trial | |
| Jones | Esophageal adenocarcinoma: Wanted—new models and better targets | |
| Coe et al. | 916 Accuracy of In Vivo Colorectal Polyp Discrimination Using Dual Focus High Definition Narrow Band Imaging Colonoscopy: A Randomized Controlled Trial; Preliminary Results | |
| Galassi | Aspetti diagnostici, strategie terapeutiche ed esito clinico dei tumori primitivi colangiocellulari insorti su cirrosi |